Wanbury P/B Ratio
Wanbury (WANBURY) P/B ratio is 10.85 (High), book value per share ₹17.88 vs Healthcare average P/B of -0.19 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Wanbury share price chart.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
WANBURY P/B Ratio — Valuation Insights & Book Value Analysis
Wanbury price-to-book ratio interpretation, valuation status and historical context — current P/B 10.85 (High). Check WANBURY market cap trends to track the company's total market size over time.
- Stock appears overvalued with PB of 10.85, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 53.8% below historical average
- Trading at premium to sector average PB of -0.19
Wanbury P/B Ratio Historical Trend
WANBURY annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Also explore Wanbury share price performance to track price trends across different timeframes.
WANBURY Historical P/B Ratio — Book Value Per Share & Year-End Price
Wanbury annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 12.67 | ₹17.88 | ₹226.60 | ₹59 | High |
| 2024 | 34.32 | ₹8.48 | ₹291.18 | ₹28 | High |
WANBURY vs Healthcare Peers — P/B Ratio Comparison
Wanbury P/B 10.85 vs Healthcare average -0.19, median 0.67 — range -13.75–1.07.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -13.75 | ₹4,814 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |